Without adequate protein intake and resistance training, a significant share of the weight lost on a GLP-1 will be lean mass rather than fat particularly concerning for older adults where sarcopenia is already a risk
In the patients (mean age of 41 years, BMI of 34 kg/m, and baseline A1C of 7.5%) who received 4.1mg of CT-868, A1C levels decreased by 0.34% from baseline, and 56% of participants achieved an A1C below 7%, the recommended A1C target for diabetes management
Research Applications Renew Spray is formulated for researchers investigating growth-related processes, exploring potential synergies between CJC-1295 No DAC and Ipamorelin, and studying therapeutic applications related to growth hormone regulation
Feb 2007;47(1):19-28
Results of the phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia
Professional support is invaluable